The latest report by IMARC Group, titled “Positive Airway Pressure Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. The global positive airway pressure devices market size reached US$ 3.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.9 Billion by 2028, exhibiting a growth rate (CAGR) of 6% during 2023-2028.

Positive airway pressure devices are medical devices used to treat sleep apnea and other respiratory conditions by providing a continuous flow of air pressure to the airways, ensuring they remain open during sleep. They work by delivering pressurized air through a mask or nasal prongs, which helps to prevent the collapse of the airway and maintain a steady flow of oxygen. They consist of several components, including a device or machine that generates the air pressure, a mask or interface that delivers the pressurized air to the patient’s airway, and tubing that connects the device to the mask. There are different types of positive airway pressure devices available in the market, including continuous positive airway pressure (CPAP), bi-level positive airway pressure (BiPAP), and adaptive servo-ventilation (ASV) devices.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/positive-airway-pressure-devices-market/requestsample

Positive Airway Pressure Devices Market Trends and Drivers:

The global positive airway pressure devices market is primarily driven by the increasing prevalence of sleep apnea and other respiratory disorders. Additionally, the rising awareness about the importance of early diagnosis and treatment of sleep-related disorders is fueling market growth. Moreover, rapid innovations in technology have led to the development of innovative and user-friendly positive airway pressure devices, enhancing patient comfort and compliance, which is offering an impetus to the market growth. Furthermore, the burgeoning geriatric population, who are more prone to sleep-related disorders, and the growing healthcare expenditure are driving the market growth. Other factors, such as the increasing adoption of home healthcare solutions and the rising demand for portable and compact PAP devices,  are creating a positive outlook for the market.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product Type:

  • Automatic Positive Airway Pressure (APAP) Devices
  • Continuous Positive Airway Pressure (CPAP) Devices
  • Bi-level Positive Airway Pressure (BiPAP) Devices

Breakup by End User:

  • Hospitals and Sleep Labs
  • Home Care
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • 3B Medical Inc.
  • Apex Medical Corp.
  • Compumedics Limited (D & DJ Burton Holdings Pty Ltd.)
  • Drive Devilbiss Healthcare (Drive International LLC)
  • Fisher & Paykel Healthcare Limited
  • Koninklijke Philips N.V.
  • Resmed Inc.
  • Smiths Group Plc
  • Somnetics International Inc.
  • Vyaire Medical Inc.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

Email: [email protected]

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal